Drug Discovery

The recent awarding of the European Research Council Advanced Grant to Christoph Bock represents a pivotal shift in the trajectory of modern oncology by prioritizing the development of sophisticated living drugs. These therapies, particularly chimeric antigen receptor (CAR) T cells, have already

The towering Art Deco facade of the historic Charity Hospital has stood as a silent sentinel over the New Orleans skyline for decades, but it is now undergoing a massive five hundred million dollar transformation led by Tulane University. This ambitious redevelopment project seeks to convert the

The landscape of botanical medicine underwent a massive transformation as pharmaceutical-grade cannabinoid research transitioned from niche experimentation to a cornerstone of modern therapeutic development. Ananda Pharma has positioned itself at the forefront of this evolution by announcing the

Modern laboratory environments are undergoing a quiet yet profound transformation as the reliance on manual pipette-wielding technicians gives way to a new era of robotic precision and high-throughput automation. This evolution is not merely a convenience but a structural necessity in a landscape

Pancreatic cancer has remained an almost invincible adversary in the medical world, frequently defying the very treatments that have successfully tamed other aggressive forms of the disease. While oncology has celebrated remarkable progress in targeted therapies, pancreatic ductal adenocarcinoma

The transformation of human hookworms from harmful intestinal parasites into sophisticated, living drug factories represents one of the most radical shifts in modern bioengineering and therapeutic delivery. While these organisms have historically been associated with disease and malnutrition in